PT1165050E - Processos para formacao de po fino - Google Patents
Processos para formacao de po finoInfo
- Publication number
- PT1165050E PT1165050E PT00921743T PT00921743T PT1165050E PT 1165050 E PT1165050 E PT 1165050E PT 00921743 T PT00921743 T PT 00921743T PT 00921743 T PT00921743 T PT 00921743T PT 1165050 E PT1165050 E PT 1165050E
- Authority
- PT
- Portugal
- Prior art keywords
- solvent
- immobilizing
- methods
- poultry
- processes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B5/00—Drying solid materials or objects by processes not involving the application of heat
- F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
- F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
- F26B5/065—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing the product to be freeze-dried being sprayed, dispersed or pulverised
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Mechanical Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Peptides Or Proteins (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12769999P | 1999-04-05 | 1999-04-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1165050E true PT1165050E (pt) | 2006-06-30 |
Family
ID=22431487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT00921743T PT1165050E (pt) | 1999-04-05 | 2000-04-05 | Processos para formacao de po fino |
Country Status (11)
Country | Link |
---|---|
US (3) | US6440463B1 (pt) |
EP (1) | EP1165050B1 (pt) |
JP (2) | JP2002540850A (pt) |
AT (1) | ATE321536T1 (pt) |
AU (2) | AU773556B2 (pt) |
CA (1) | CA2367131C (pt) |
DE (1) | DE60026982T2 (pt) |
DK (1) | DK1165050T3 (pt) |
ES (1) | ES2261195T3 (pt) |
PT (1) | PT1165050E (pt) |
WO (1) | WO2000059476A1 (pt) |
Families Citing this family (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6428771B1 (en) * | 1995-05-15 | 2002-08-06 | Pharmaceutical Discovery Corporation | Method for drug delivery to the pulmonary system |
PT1165050E (pt) * | 1999-04-05 | 2006-06-30 | Mannkind Corp | Processos para formacao de po fino |
US9006175B2 (en) * | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
DK1808438T3 (da) * | 1999-06-29 | 2014-10-27 | Mannkind Corp | Rensning og stabilisering af peptid og proteiner i lægemidler |
US6284283B1 (en) * | 1999-10-21 | 2001-09-04 | Alkermes Controlled Therapeutics, Inc. | Method of producing sub-micron particles of biologically active agents and uses thereof |
GB0004827D0 (en) * | 2000-02-29 | 2000-04-19 | Quadrant Holdings Cambridge | Compositions |
US6824822B2 (en) | 2001-08-31 | 2004-11-30 | Alkermes Controlled Therapeutics Inc. Ii | Residual solvent extraction method and microparticles produced thereby |
FR2834636B1 (fr) * | 2002-01-15 | 2006-02-24 | El Hassane Larhrib | Procede de fabrication de particules micro-poreuses creuses, notamment destinees a etre inhalees |
US6923175B2 (en) | 2002-03-20 | 2005-08-02 | Mannkind Corporation | Inhalation apparatus |
US8372804B2 (en) * | 2007-10-24 | 2013-02-12 | Mannkind Corporation | Delivery of active agents |
US20080260838A1 (en) * | 2003-08-01 | 2008-10-23 | Mannkind Corporation | Glucagon-like peptide 1 (glp-1) pharmaceutical formulations |
GB0327723D0 (en) | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
US7338171B2 (en) * | 2003-10-27 | 2008-03-04 | Jen-Chuen Hsieh | Method and apparatus for visual drive control |
WO2005061088A1 (en) * | 2003-12-22 | 2005-07-07 | Finlay Warren H | Powder formation by atmospheric spray-freeze drying |
JP2007517892A (ja) | 2004-01-12 | 2007-07-05 | マンカインド コーポレイション | 2型糖尿病における血清プロインスリンレベルを低下させる方法 |
US20070027063A1 (en) * | 2004-01-12 | 2007-02-01 | Mannkind Corporation | Method of preserving the function of insulin-producing cells |
US20080090753A1 (en) * | 2004-03-12 | 2008-04-17 | Biodel, Inc. | Rapid Acting Injectable Insulin Compositions |
WO2005089722A1 (en) * | 2004-03-12 | 2005-09-29 | Biodel, Inc. | Rapid acting drug delivery compositions |
US20080248999A1 (en) * | 2007-04-04 | 2008-10-09 | Biodel Inc. | Amylin formulations |
JP5030292B2 (ja) | 2004-04-15 | 2012-09-19 | アミリン・ファーマシューティカルズ,インコーポレイテッド | ポリマーを基にした持続放出性装置 |
US7456254B2 (en) | 2004-04-15 | 2008-11-25 | Alkermes, Inc. | Polymer-based sustained release device |
WO2006124047A2 (en) * | 2004-08-13 | 2006-11-23 | Emisphere Technologies, Inc. | Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent |
PL1786784T3 (pl) | 2004-08-20 | 2011-04-29 | Mannkind Corp | Kataliza syntezy diketopiperazyn |
EP1781254A2 (en) * | 2004-08-23 | 2007-05-09 | Mannkind Corporation | Pulmonary delivery of inhibitors of phosphodiesterase type 5 |
CN104436170B (zh) | 2004-08-23 | 2018-02-23 | 曼金德公司 | 用于药物输送的二酮哌嗪盐 |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
WO2007033316A2 (en) | 2005-09-14 | 2007-03-22 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces |
US8084420B2 (en) * | 2005-09-29 | 2011-12-27 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
US7713929B2 (en) | 2006-04-12 | 2010-05-11 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
WO2007041481A1 (en) * | 2005-09-29 | 2007-04-12 | Biodel, Inc. | Rapid acting and prolonged acting insulin preparations |
EP1798504A1 (en) * | 2005-12-19 | 2007-06-20 | Koninklijke Philips Electronics N.V. | Method of making dried particles |
CN101389348A (zh) * | 2006-02-22 | 2009-03-18 | 曼金德公司 | 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法 |
WO2007121256A2 (en) * | 2006-04-12 | 2007-10-25 | Biodel, Inc. | Rapid acting and long acting insulin combination formulations |
EP2049081B1 (en) | 2006-08-09 | 2012-11-14 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies |
PT2157967E (pt) | 2007-04-23 | 2013-04-03 | Intarcia Therapeutics Inc | Formulações de suspensões de péptidos insulinotrópicos e suas utilizações |
US8785396B2 (en) | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
JP2011500850A (ja) | 2007-10-24 | 2011-01-06 | マンカインド コーポレイション | Glp−1による副作用を防止する方法 |
US8343140B2 (en) | 2008-02-13 | 2013-01-01 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
CN109568740B (zh) | 2008-06-13 | 2022-05-27 | 曼金德公司 | 干粉吸入器和用于药物输送的系统 |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
CN102065942B (zh) | 2008-06-20 | 2013-12-11 | 曼金德公司 | 用于对吸入工作进行实时描绘的交互式设备和方法 |
TWI494123B (zh) | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US9060927B2 (en) * | 2009-03-03 | 2015-06-23 | Biodel Inc. | Insulin formulations for rapid uptake |
US8538707B2 (en) | 2009-03-11 | 2013-09-17 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
JP5859433B2 (ja) | 2009-06-12 | 2016-02-10 | マンカインド コーポレイション | 規定された比表面積を有するジケトピペラジン微粒子 |
CA2775676C (en) | 2009-09-28 | 2016-08-16 | Intarcia Therapeutics, Inc. | Rapid establishment and/or termination of substantial steady-state drug delivery |
WO2011056889A1 (en) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | An apparatus and method for simulating inhalation efforts |
EP2567219B1 (en) | 2010-05-07 | 2019-09-18 | MannKind Corporation | Method and apparatus for determining weight percent of microparticles of diketopiperazine in suspension using raman spectroscopy |
JP6385673B2 (ja) | 2010-06-21 | 2018-09-05 | マンカインド コーポレイション | 乾燥粉末薬物送達システム |
GB201016436D0 (en) | 2010-09-30 | 2010-11-17 | Q Chip Ltd | Method of making solid beads |
GB201016433D0 (en) | 2010-09-30 | 2010-11-17 | Q Chip Ltd | Apparatus and method for making solid beads |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
DK2694402T3 (en) | 2011-04-01 | 2017-07-03 | Mannkind Corp | BLISTER PACKAGE FOR PHARMACEUTICAL CYLINDER AMPULS |
US9890200B2 (en) | 2011-04-12 | 2018-02-13 | Moerae Matrix, Inc. | Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition |
SG10201604560TA (en) | 2011-04-12 | 2016-07-28 | Moerae Matrix Inc | Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
FR2981287B1 (fr) * | 2011-10-13 | 2013-12-27 | Commissariat Energie Atomique | Appareil et procede de decoupe au laser a impulsions de gaz asservies en frequence ou en pression |
JP6018640B2 (ja) | 2011-10-24 | 2016-11-02 | マンカインド コーポレイション | 疼痛を緩和するのに有効な鎮痛組成物並びに当該組成物を含む乾燥粉末及び乾燥粉末薬剤輸送システム |
SG11201500218VA (en) | 2012-07-12 | 2015-03-30 | Mannkind Corp | Dry powder drug delivery systems and methods |
WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
SG10201708090TA (en) | 2013-03-15 | 2017-11-29 | Mannkind Corp | Microcrystalline diketopiperazine compositions and methods |
BR112016000937A8 (pt) | 2013-07-18 | 2021-06-22 | Mannkind Corp | formulações farmacêuticas de pó seco, método para a fabricação de uma formulação de pó seco e uso de uma formulação farmacêutica de pó seco |
US11446127B2 (en) | 2013-08-05 | 2022-09-20 | Mannkind Corporation | Insufflation apparatus and methods |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10336788B2 (en) | 2014-04-17 | 2019-07-02 | Moerae Matrix, Inc. | Inhibition of cardiac fibrosis in myocardial infarction |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
CN107106650A (zh) | 2014-11-17 | 2017-08-29 | 莫伊莱麦屈克斯公司 | 用于预防或治疗表征为异常的成纤维细胞增殖和细胞外基质沉积的疾病、状况或过程的组合物和方法 |
BR112017019343A2 (pt) | 2015-03-12 | 2018-05-02 | Moerae Matrix Inc | uso de composições contendo peptídeo inibidor de mk2 para tratamento de câncer de pulmão de células não pequenas com as mesmas |
RU2730996C2 (ru) | 2015-06-03 | 2020-08-26 | Интарсия Терапьютикс, Инк. | Системы установки и извлечения имплантата |
TWI814219B (zh) | 2016-05-16 | 2023-09-01 | 美商因塔希亞治療公司 | 升糖素受體選擇性多肽和彼之使用方法 |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
CA3049034A1 (en) | 2017-01-03 | 2018-07-12 | Intarcia Therapeutics, Inc. | Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3673698A (en) * | 1970-11-25 | 1972-07-04 | Albert S Guerard | Process for freeze drying with carbon dioxide |
US3873651A (en) * | 1972-05-12 | 1975-03-25 | Atomic Energy Commission | Freeze drying method for preparing radiation source material |
US4981625A (en) | 1988-03-14 | 1991-01-01 | California Institute Of Technology | Monodisperse, polymeric microspheres produced by irradiation of slowly thawing frozen drops |
GB8813338D0 (en) * | 1988-06-06 | 1988-07-13 | Osprey Metals Ltd | Powder production |
US5019400A (en) | 1989-05-01 | 1991-05-28 | Enzytech, Inc. | Very low temperature casting of controlled release microspheres |
DK0432232T3 (da) | 1989-05-01 | 1994-01-31 | Alkermes Inc | Fremgangsmåde til fremstilling af små partikler af biologisk aktive molekyler |
US5017383A (en) | 1989-08-22 | 1991-05-21 | Taisho Pharmaceutical Co., Ltd. | Method of producing fine coated pharmaceutical preparation |
US5208998A (en) * | 1991-02-25 | 1993-05-11 | Oyler Jr James R | Liquid substances freeze-drying systems and methods |
ES2284226T3 (es) | 1991-07-02 | 2007-11-01 | Nektar Therapeutics | Dispositivo para proporcionar medicamentos en aerosol. |
US5639441A (en) * | 1992-03-06 | 1997-06-17 | Board Of Regents Of University Of Colorado | Methods for fine particle formation |
EP0695171B1 (en) * | 1993-04-28 | 1996-12-18 | Akzo Nobel N.V. | Lyospheres comprising gonadotropin |
EP0742888B1 (en) * | 1994-02-09 | 1998-04-22 | Kinerton Limited | Process for drying a material from solution |
CZ295827B6 (cs) | 1994-03-07 | 2005-11-16 | Nektar Therapeutics | Způsob aerosolizace dávky inzulinu, inzulinový přípravek a jeho použití |
US6051256A (en) | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
SA95160463B1 (ar) | 1994-12-22 | 2005-10-04 | استرا أكتيبولاج | مساحيق للاستنشاق |
US5922253A (en) * | 1995-05-18 | 1999-07-13 | Alkermes Controlled Therapeutics, Inc. | Production scale method of forming microparticles |
GB9606188D0 (en) | 1996-03-23 | 1996-05-29 | Danbiosyst Uk | Pollysaccharide microspheres for the pulmonary delivery of drugs |
US5817343A (en) | 1996-05-14 | 1998-10-06 | Alkermes, Inc. | Method for fabricating polymer-based controlled-release devices |
PT1165050E (pt) * | 1999-04-05 | 2006-06-30 | Mannkind Corp | Processos para formacao de po fino |
WO2001045731A1 (en) | 1999-12-21 | 2001-06-28 | Rxkinetix, Inc. | Particulate drug-containing products and method of manufacture |
WO2003012121A2 (en) * | 2001-07-31 | 2003-02-13 | The General Hospital Corporation | Collagen xxii, a novel human collagen and uses thereof |
-
2000
- 2000-04-05 PT PT00921743T patent/PT1165050E/pt unknown
- 2000-04-05 ES ES00921743T patent/ES2261195T3/es not_active Expired - Lifetime
- 2000-04-05 DE DE60026982T patent/DE60026982T2/de not_active Expired - Lifetime
- 2000-04-05 US US09/543,309 patent/US6440463B1/en not_active Expired - Lifetime
- 2000-04-05 CA CA002367131A patent/CA2367131C/en not_active Expired - Fee Related
- 2000-04-05 WO PCT/US2000/009085 patent/WO2000059476A1/en active IP Right Grant
- 2000-04-05 EP EP00921743A patent/EP1165050B1/en not_active Expired - Lifetime
- 2000-04-05 AT AT00921743T patent/ATE321536T1/de not_active IP Right Cessation
- 2000-04-05 DK DK00921743T patent/DK1165050T3/da active
- 2000-04-05 JP JP2000609040A patent/JP2002540850A/ja active Pending
- 2000-04-05 AU AU42019/00A patent/AU773556B2/en not_active Revoked
-
2002
- 2002-08-20 US US10/224,676 patent/US7278843B2/en not_active Expired - Fee Related
-
2004
- 2004-08-13 AU AU2004203885A patent/AU2004203885B2/en not_active Ceased
-
2005
- 2005-10-06 JP JP2005294208A patent/JP2006028198A/ja active Pending
-
2006
- 2006-03-21 US US11/385,513 patent/US7794754B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20020193290A1 (en) | 2002-12-19 |
US7278843B2 (en) | 2007-10-09 |
AU2004203885B2 (en) | 2007-08-30 |
ES2261195T3 (es) | 2006-11-16 |
JP2002540850A (ja) | 2002-12-03 |
WO2000059476A1 (en) | 2000-10-12 |
CA2367131A1 (en) | 2000-10-12 |
AU773556B2 (en) | 2004-05-27 |
EP1165050A1 (en) | 2002-01-02 |
ATE321536T1 (de) | 2006-04-15 |
DE60026982T2 (de) | 2006-11-16 |
DK1165050T3 (da) | 2006-05-01 |
US6440463B1 (en) | 2002-08-27 |
US20060191375A1 (en) | 2006-08-31 |
EP1165050B1 (en) | 2006-03-29 |
CA2367131C (en) | 2007-07-03 |
AU4201900A (en) | 2000-10-23 |
US7794754B2 (en) | 2010-09-14 |
JP2006028198A (ja) | 2006-02-02 |
DE60026982D1 (de) | 2006-05-18 |
AU2004203885A1 (en) | 2004-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1165050E (pt) | Processos para formacao de po fino | |
ATE223274T1 (de) | Entfernung von bindemittel | |
JP3094181B2 (ja) | 再生天然ケラチンを壁材とするマイクロカプセル及びその製造方法 | |
FR2753639B1 (fr) | Procede de preparation de microcapsules de matieres actives enrobees par un polymere et nouvelles microcapsules notamment obtenues selon le procede | |
GR920100323A (el) | Μία μέ?οδος παρασκευής μικροσφαιρίων αποτελούμενων από ένα βιοαποικοδομούμενο πολυμερικό υλικό. | |
CA2451408A1 (en) | The production of soluble keratin derivatives | |
CY1107059T1 (el) | Υδατικη διασπορα που περιεχει σταθερα νανοσωματιδια μιας αδιαλυτης στο νερο δραστικης ουσιας κι ενα εκδοχο οπως τα τριγλυκεριδια μεσης αλυσιδας (mct) | |
WO2003064407A3 (en) | Production of δ9 tetrahydrocannabinol | |
JP3283302B2 (ja) | 還元ケラチンの製造方法 | |
MX166885B (es) | Metodos de purificacion y reactivacion de proteinas heterologas precipitadas | |
ATE349460T1 (de) | Rückfaltung von protein-aggregaten und einschlussteilchen durch hohen druck | |
DE69033600D1 (de) | Verfahren zur Isolierung von Haemopnilus influenzae Protein-E | |
DE60226229D1 (de) | En derivaten | |
DK1016347T3 (da) | Fremgangsmåde til fremstilling af fiskegelatine | |
NO900591L (no) | Fremgangsmaate for fremstilling av mikrobaerere for opploesningsmiddelfortynning. | |
DK1061948T3 (da) | Præparat til vedvarende frigivelse af et fysiologisk aktivt polypeptid samt fremstilling deraf | |
DE60026587D1 (de) | Wässrige kolloidaldispersionen von sulfonierten polyurethanharnstoffen und produkten | |
UA48944C2 (uk) | Спосіб одержання солі клавуланової кислоти | |
ATE484607T1 (de) | Mikrowellenplasmaverarbeitungsverfahren | |
ES520493A0 (es) | Procedimiento para la preparacion de insulinas a partir de compuestos analogos a preproinsulina. | |
DE69935433D1 (de) | Neuer wirkstoffträger für die gefriertrocknung von wässrigen suspensionen von mikropartikeln | |
ATE522544T1 (de) | Verfahren zur gewinnung und reinigung von rekombinantem protein aus zellen | |
DE50012577D1 (de) | Verfahren zur trocknung von proteinkristallen | |
ES2137487T3 (es) | Procedimiento para la preparacion de proteinas de una sustancia con contenido en proteinas. | |
BR9611125A (pt) | Gránulos redispersíveis em água e processo para preparar os mesmos |